Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United
States. While the American Association for the Study of Liver Diseases guidelines define …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease. The progressive subtype of NAFLD or nonalcoholic steatohepatitits (NASH), may …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The
prevalence in patients with type 2 diabetes mellitus is between 55–80%. The spectrum of …

Abstract Background & Aims Liver ultrasound (US) is usually used in the clinical setting for
the diagnosis and follow‐up of patients with nonalcoholic fatty liver disease (NAFLD) …

Non-alcoholic fatty liver disease is a condition that is characterized by the presence of> 5%
fat in the liver and affects more than one billion people worldwide. If adequate and early …

Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …

We review the role of liver ultrasonography (US) and related techniques as non-invasive
tools in predicting metabolic derangements, liver histology, portal hypertension and …

Introduction: Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). NAFLD …

Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Quantitative ultrasound (QUS) parameters based on radiofrequency raw …